Skip to main content

Table 4 Number and percentage of false negative, minimal sign significant, minimal sign non-specific, and true cancers on screening examinations prior to interval cancer (n = 19) and resulting in consecutive round screen-detected cancer (n = 91) based on the informed consensus-based review

From: Digital breast tomosynthesis in mammographic screening: false negative cancer cases in the To-Be 1 trial

 

Screening examinations prior to interval cancer (n = 19)

Screening examinations resulting in consecutive round screen-detected cancer (n = 91)

Total (n = 110)

n

% (fraction)

n

% (fraction)

n

% (fraction)

False negative

1

5.3 (1/19)

17

18.7 (17/91)

18

16.4 (18/110)

Minimal sign significant

2

10.5 (2/19)

14

15.4 (14/91)

16

14.5 (16/110)

Minimal sign non-specific

2

10.5 (2/19)

14

15.4 (14/91)

16

14.5 (16/110)

True

14

73.7 (14/19)

46

50.6 (46/91)

60

54.6 (60/110)